CytomX Therapeutics CTMX
NASDAQ CTMX
$2.56 -0.07 (-2.66%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Depreciation and Depletion (2016 - 2017)

Updated

CytomX Therapeutics (CTMX) reported Depreciation and Depletion of $1.2 million for FY2025, down 25.0% from $1.6 million in FY2024.

Analysis

CytomX Therapeutics (CTMX) Depreciation and Depletion (2016 - 2017) Analysis & Trends

Dating back to FY2015, CytomX Therapeutics' Depreciation and Depletion record includes 11 years.

  • Depreciation and Depletion has declined for four consecutive years, with a five-year compound annual growth rate of -12.9% (FY2020 to FY2025).
  • According to Business Quant data, Depreciation and Depletion came in at $1.6 million in FY2024 (-20.0%), $2 million in FY2023 (-13.0%), $2.3 million in FY2022 (-11.5%) and $2.6 million in FY2021 (+8.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 CytomX Therapeutics 573.08 Mn -384.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 400,000.00
Sep 30, 2017 368,000.00
Dec 31, 2016 500,000.00
Sep 30, 2016 443,000.00
API Access

CytomX Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=CTMX&period=max&api_key=YOUR_API_KEY